The metabolic dysfunction-associated fatty liver illness (MAFLD) exhibits several aspects of the pathophysiology observed in metabolic syndrome due to overweight and obesity, high cholesterol levels, resistance to insulin, mitochondrial damage, an oxidative stress reaction and the production of inflammatory cytokines [53]. This evidence concerns the gene INS and metabolic syndrome.